<DOC>
	<DOC>NCT00047567</DOC>
	<brief_summary>To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.</brief_summary>
	<brief_title>Open-label Adjunctive Zonisamide for Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>Bipolar I/II Average intelligence Taking at least one, but no more than two mood stabilizers</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ZONISAMIDE</keyword>
	<keyword>BIPOLAR</keyword>
</DOC>